Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-12-035053

Options or other derivatives

  • Executive Vice President & CFO acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Amello Jason Executive Vice President & CFO 2012-06-20 Grant or award · Employee Stock Option (right to buy) +200,000 200,000 D
Loading xslF345X03/doc4.xml…